Chemotherapy-Associated Liver Injury: Impact on Surgical Management of Colorectal Cancer Liver Metastases

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Annals of Surgical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-010-1201-2PMID 20645011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases.

  2010cited by this paper
• Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection.

  2009cited by this paper
• Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases.

  2009cited by this paper
• Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases.

  2009cited by this paper
• Quantitative analysis of T2‐correction in single‐voxel magnetic resonance spectroscopy of hepatic lipid fraction

  2009cited by this paper
• Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.

  2009cited by this paper
• Ursodeoxycholic acid switches oxaliplatin‐induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53‐caspase 8 pathway in HepG2 hepatocellular carcinoma

  2009cited by this paper
• Assessment of Hepatic Steatosis by Expert Pathologists: The End of a Gold Standard

  2009cited by this paper
• Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.

  2008cited by this paper
• Sinusoidal Injury Increases Morbidity After Major Hepatectomy in Patients With Colorectal Liver Metastases Receiving Preoperative Chemotherapy

  2008cited by this paper
• Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases.

  2008cited by this paper
• Preoperative Chemotherapy Does Not Increase Morbidity or Mortality of Hepatic Resection for Colorectal Cancer Metastases

  2008cited by this paper
• Preoperative radiographic assessment of hepatic steatosis with histologic correlation.

  2008cited by this paper
• Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.

  2008cited by this paper
• Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

  2008cited by this paper
• Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis

  2007cited by this paper
• Safe liver resection following chemotherapy for colorectal metastases is a matter of timing

  2007cited by this paper
• Preoperative Chemotherapy for Colorectal Liver Metastases: Impact on Hepatic Histology and Postoperative Outcome

  2007cited by this paper
• Chemotherapy‐associated hepatotoxicity and surgery for colorectal liver metastases

  2007cited by this paper
• Preoperative Chemotherapy and the Outcome of Liver Resection for Colorectal Metastases

  2007cited by this paper
• Hepatic Steatosis Is a Risk Factor for Postoperative Complications After Major Hepatectomy: A Matched Case-Control Study

  2007cited by this paper
• The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study

  2007cited by this paper
• Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri‐operative outcomes

  2007cited by this paper
• Postoperative Liver Dysfunction and Future Remnant Liver: Where Is the Limit?

  2007cited by this paper
• Severe Steatosis Increases Hepatocellular Injury and Impairs Liver Regeneration in a Rat Model of Partial Hepatectomy

  2007cited by this paper
• Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases

  2007cited by this paper
• Computed Tomography Features of Nonalcoholic Steatohepatitis With Histopathologic Correlation

  2006cited by this paper
• Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement

  2006cited by this paper
• CASH (Chemotherapy-Associated Steatohepatitis) costs.

  2006cited by this paper
• Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver Metastases

  2006cited by this paper
• Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

  2006cited by this paper
• Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.

  2006cited by this paper
• Histological assessment of non‐alcoholic fatty liver disease

  2006cited by this paper
• Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases.

  2006cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases.

  2005cited by this paper
• Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

  2005cited by this paper
• Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection

  2005cited by this paper
• Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

  2005cited by this paper
• Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

  2004cited by this paper
• Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases

  2004cited by this paper
• FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

  2004cited by this paper
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.

  2004cited by this paper
• Five-Year Survival After Resection of Hepatic Metastases From Colorectal Cancer in Patients Screened by Positron Emission Tomography With F-18 Fluorodeoxyglucose (FDG-PET)

  2004cited by this paper
• Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection

  2003cited by this paper
• Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy

  2003cited by this paper
• Influence of Transfusions on Perioperative and Long-Term Outcome in Patients Following Hepatic Resection for Colorectal Metastases

  2003cited by this paper
• Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial

  2003cited by this paper
• Impact of steatosis on perioperative outcome following hepatic resection

  2003cited by this paper
• Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver

  2003cited by this paper
• Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness--study in 26 patients.

  2003cited by this paper
• Alcoholic steatosis and steatohepatitis.

  2002cited by this paper
• Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines.

  2002cited by this paper
• The utility of radiological imaging in nonalcoholic fatty liver disease.

  2002cited by this paper
• Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases

  2002cited by this paper
• Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system.

  2002cited by this paper
• Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

  2002cited by this paper
• Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat.

  2001cited by this paper
• Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway

  2000cited by this paper
• Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.

  2000cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations.

  2000cited by this paper
• Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection.

  2000cited by this paper
• Use of phosphorous-31 nuclear magnetic resonance spectroscopy to determine safe timing of chemotherapy after hepatic resection.

  2000cited by this paper
• Continuous versus intermittent portal triad clamping for liver resection: a controlled study.

  1999cited by this paper
• Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

  1999cited by this paper
• Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.

  1998cited by this paper
• Hepatic steatosis as a potential risk factor for major hepatic resection

  1998cited by this paper
• Hepatic steatosis: Innocent bystander or guilty party?

  1998cited by this paper
• The natural history of nonalcoholic fatty liver: A follow‐up study

  1995cited by this paper
• Reversible hepatic steatosis in patients treated with interferon alfa‐2A and 5‐fluorouracil

  1995cited by this paper
• Hepatic resection with ischemia of the liver exceeding one hour.

  1994cited by this paper
• Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.

  1993cited by this paper
• The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation.

  1991cited by this paper
• Fatty Liver Change as a Result of Hepatic Artery Infusion Chemotherapy

  1990cited by this paper
• Resection of hepatic metastases from colorectal cancer.

  1984cited by this paper
• Fatty changes in the liver: the relation to age, overweight and diabetes mellitus.

  1982cited by this paper
• Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties.

  1977cited by this paper
• Edinburgh Research Explorer Guidelines for Resection of Colorectal Cancer Liver Metastases

  year unknowncited by this paper

• PNPLA3 polymorphism worsens chemotherapy associated liver injury and affects overall survival in colorectal cancer patients with liver metastasis undergoing hepatic resection

  2025cites this paper
• Surgical Management of Colorectal Cancer Liver Metastases.

  2025cites this paper
• Preoperative Imaging of Colorectal Liver Metastases: What the Radiologist and the MDT Need to Know.

  2024cites this paper
• Liver cirrhosis following oxaliplatin-based adjuvant chemotherapy for rectal cancer

  2023cites this paper
• CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies.

  2023cites this paper
• Polyunsaturated fatty acids drive neutrophil extracellular trap formation in nonalcoholic steatohepatitis.

  2023cites this paper
• Remote ischemic preconditioning for reduction of ischemia-reperfusion injury after hepatectomy: A randomized sham-controlled trial.

  2023cites this paper
• Liver Transplantation as a Curative Approach for Patients With Nonresectable Colorectal Liver Metastases.

  2022cites this paper
• Long-Term Outcomes of Perioperative Versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases: An International Multicentre Propensity-Score Matched Analysis with Stratification by Contemporary Risk-Scoring

  2022cites this paper
• Clearing Steatosis Prior to Liver Surgery for Colorectal Metastasis: A Narrative Review and Case Illustration

  2021cites this paper
• Liver surface nodularity: a novel predictor of post-hepatectomy liver failure in patients with colorectal liver metastases following chemotherapy

  2021cites this paper
• Surgical Management of Colorectal Cancer Liver Metastases.

  2021cites this paper
• Colorectal Liver Metastasis: Current Concepts

  2020cites this paper
• Chemotherapy-associated liver injury in colorectal cancer

  2020cites this paper
• Diagnostic value/performance of radiological liver imaging during chemoterapy for gastrointestinal malignancy: a critical review

  2019cites this paper
• Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases

  2019cites this paper
• High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases

  2019cites this paper
• Perioperativer Umgang mit antitumoralen Medikamenten

  2018cites this paper
• Chemotherapy-induced liver injury in metastatic colorectal cancer: about 48 cases

  2018cites this paper
• Polyene phosphatidylcholine overcomes oxaliplatin resistance in human gastric cancer BGC823 cells.

  2018cites this paper
• The outcomes of central hepatectomy versus extended hepatectomy: a systematic review and meta-analysis.

  2018cites this paper
• Metastatic Liver Disease: Associated Liver Lesions

  2017cites this paper
• Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis

  2017cites this paper
• Sinusoidal obstruction syndrome in the animal model: influence on liver surgery

  2017cites this paper
• Comparative Effectiveness of Minimally Invasive Surgery and Conventional Approaches for Major or Challenging Hepatectomy.

  2016cites this paper
• Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases

  2016cites this paper
• Effect of Remote Ischaemic Preconditioning on Liver Injury in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastasis: A Pilot Randomised Controlled Feasibility Trial

  2016cites this paper
• Target hepatic artery regional chemotherapy and bevacizumab perfusion in liver metastatic colorectal cancer after failure of first-line or second-line systemic chemotherapy

  2016cites this paper
• Einfluss einer Lebersteatose auf die Detektionsleistung mit Gd-EOB-DTPA in der Magnetresonanztomografie

  2016cites this paper
• Look-up table based Monte Carlo inverse model as a tool to discover liver tumors

  2015cites this paper
• Diffuse reflectance spectroscopy of liver tissue

  2015cites this paper
• Facteurs de risque et impact clinique de l'hépatotoxicité des chimiothérapies dans le cancer colorectal métastatique

  2014cites this paper
• Current management of colorectal liver metastases

  2014cites this paper
• Hepatoprotective Effects of B-1,3-(D)-Glucan on Bortezomib- Induced Liver Damage in Rats

  2014cites this paper
• Sıçanlarda Bortezomib İndüklü Karaciğer Hasarında B-1,3-(D)-Glukan’ın Hepatoprotektif Etkileri

  2014cites this paper
• The Role of Tiopronin for the Prevention of Chemotherapy-Related Liver Toxicity in Advanced Colorectal Cancer Patients Treated with mFOLFOX7: A Prospective Analysis

  2014cites this paper
• Stereotactic body radiation therapy for liver tumors.

  2014cites this paper
• Flu-Like Symptoms Following Radiofrequency Liver Transection: A New Variety of the Post-Radiofrequency Syndrome

  2014cites this paper
• Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy

  2014cites this paper
• A comparison of right posterior sectorectomy with formal right hepatectomy: a dual-institution study.

  2013cites this paper
• A Case of Liver Fibrosis with Splenomegaly after Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer

  2013cites this paper
• Surgery for Colorectal Liver Metastases

  2013cites this paper
• Metastatic Lesions to the Liver

  2013cites this paper
• A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics

  2013cites this paper
• Modern oncosurgical treatment strategies for synchronous liver metastases from colorectal cancer

  2013cites this paper
• Antibody-targeted immunoliposomes for cancer treatment.

  2013cites this paper
• Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience.

  2013cites this paper
• Resectable liver metastases from colorectal cancer: where we are now and where do we go from here?

  2012cites this paper
• Perioperative management of hepatic resection.

  2012cites this paper
• Influence of Hepatic Parenchymal Histology on Outcome Following Right Hepatic Trisectionectomy

  2012cites this paper
• 24. Laparoscopic Liver Resection

  2012cites this paper
• Hepatic venous outflow reconstruction using an external iliac vein graft for hepatic malignancies (with video)

  2012cites this paper
• Update on the optimal management of patients with colorectal liver metastases.

  2012cites this paper
• Forty-nine colorectal cancer liver metastases in one-stage hepatectomy with cumulative Pringle time lasting 348 min

  2012cites this paper
• Chemotherapy-Associated Hepatopathy in Korean Colorectal Cancer Liver Metastasis Patients: Oxaliplatin-Based Chemotherapy and Sinusoidal Injury

  2012cites this paper
• Liver metastases from colorectal cancer: how to best complement medical treatment with surgical approaches.

  2011cites this paper
• Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model.

  2011cites this paper
• Recent advances in medical liver disease

  2011cites this paper
• Alteration of liver fat metabolism following irinotecan plus 5-fluorouracil treatment

  2011cites this paper